New Jersey. I am drawn to the company because of its transformative science and the potential of its portfolio to continue delivering breakthrough medicines. Other executives include Cari Gallman, Chief Compliance and Ethics Officer; Samit Hirawat, Executive Vice President, Chief Medical Officer, Global Drug Development and 47 others. "We are pleased to welcome Dr. Deepak L. Bhatt to our Board of Directors," said Giovanni Caforio, M.D., board . NEW YORK -- (BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected Karen Vousden, Ph.D., to the Board, effective January 1, 2018. Bristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and more. Today our CEO, Giovanni Caforio, becomes chairman of the PhRMA board of directors and will play a leading role in the global dialogue on healthcare, patient access and delivering innovative medicines to treat the world's most challenging diseases. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022. Through his role as a physician and leading researcher in cardiovascular medicine, Deepaks insight and expertise will be beneficial as we continue to progress our long-term strategy, transform our pipeline and bring best-in-class medicines that benefit patients with serious unmet diseases.. Board of Directors. He will receive compensation in accordance with the companys director compensation program. Dr. Bhatt will serve as a member of the Science & Technology Committee of the Board of Directors. Mr. Rice, 55, has served as the EVP of global services and CFO for Eli Lilly and Company. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. Bristol-Myers Squibb's Vice President, Chief Diversity and Inclusion Officer is Pamela Fisher. Bristol Myers Squibb Board Elects Two New Independent Directors. Media: Carrie Fernandez, 609-252-5222 Carrie.Fernandez@bms.com Investors: Tim Power, 609-252-7509 timothy.power@bms.com, Bristol-Myers Squibb Board Announces Election of Three New Directors. He brings to the Board more than 20 years of experience in translational and clinical research in anticancer drug development with a particular emphasis in gastrointestinal cancers. Ms. Price, 58, has more than 30 years of financial and operational experience. From January to July 2016, he was a Partner of Third Rock Ventures, LLC. Composition and structure of the board Expand All 1. At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. Ms. Reeve was Senior Director of Research Operations at Merck Research Laboratories from 2004 to 2006. I am extremely pleased to add Michael, Julia and Phyllis to Bristol-Myers Squibbs Board. Paulas strategic leadership, and breadth of expertise combined with Dericas expansive industry knowledge bring important added experience and value to an already strong Board. Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of fifty-four cents ($0.54) per share on the $.10 par value common stock of. Prior to his current position, Dr. Bhatt served as chief of cardiology at VA Boston Healthcare from 2008-2013. The directors guide the direction and strategy of Bristol Myers Squibb. Chief of the Division of Hematology and Medical Oncology, Weill Cornell Medicine and New York-Presbyterian/Weill Cornell Medical Center (Photo: Business Wire), We are delighted to welcome Manny to our Board of Directors, said Giovanni Caforio, M.D., board chair and chief executive officer, Bristol Myers Squibb. Bristol-Myers Squibb. BriaCell also announces that its Board of Directors has approved a grant of 10,000 options to purchase common shares in the . He has served as a member of the Company's board of directors since 2014. Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. 41 related questions found. Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, announced a $25 million equity investment from Bristol Myers Squibb and a term loan facility with access to up to $125 million from Hercules Capital, Inc. NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb Diabetes Drugs. Jennifer Torres Dr. Bhatt will serve as a member of the Science & Technology Committee of the Board of Directors. I am excited to welcome Paula and Derica to our Board during a transformative time for the company and our industry, said Giovanni Caforio, M.D., board chair and chief executive officer of Bristol Myers Squibb. This press release features multimedia. He completed his residency training in medical oncology at the Hospital 12 de Octubre in Madrid and his fellowship in medical oncology at the University of Texas Health Science Center in San Antonio, where he also served as an assistant professor of medicine. NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Manuel Hidalgo Medina, M.D., Ph.D., to the Board, effective June 1, 2021. Learn more about the company's ultimate decision-making body. In oncology, hematology, immunology and cardiovascular disease - and one of the most diverse and promising pipelines in the industry - each of our passionate colleagues contribute to innovations that drive meaningful change. John L. Damonti Mr. Bonney and Dr. Haller currently serve on Celgenes Board of Directors. Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has appointed Robert J. Bertolini, Matthew W. Emmens and Theodore R. Samuelsto its Board of Directors, effective immediately. April 25, 2012, 10:42 AM. Bristol-Myers Squibb: Board Proposals 1. She currently serves on the Celgene Board of Directors, where she is a member of the Audit Committee. He also held the position of the Theodore W. and Evelyn G. Berenson Professor of Medicine at Harvard Medical School. President, US Pharmaceuticals. Bristol-Myers Squibb is a great place to work. It is an honor to join the Board, and I look forward to working alongside with my fellow directors to help build upon the companys legacy of innovation to the benefit of more patients around the world.. Bristol-Myers Squibb Board Announces Election of Three New Directors: Mr. Michael Bonney, Dr. Julia A. Haller and Ms. Phyllis Yale to Join BMS Board Media: Carrie Fernandez, 609-252-5222. Prior to his current position, Dr. Hidalgo served as chief of the division of hematology at Beth Israel Deaconess Medical Center in Boston and as clinical director of the Rosenberg Clinical Cancer Center from 2015-2019. Ms. Price earned her master's degree in business administration from the University of Chicago and her Bachelor of Science degree in accountancy from DePaul University. The additional clinical expertise will prove valuable as we progress our pipeline and help ensure that our patients and shareholders continue to benefit from diverse experiences and perspectives on our board., Dr. Bhatt commented, As a recognized leader in the development of transformational medicines, including for cardiovascular disease, Bristol Myers Squibb continues to innovate and develop first-in-class medicines that have the potential to benefit patients with serious unmet needs. (AP) -- Shareholders of chemical company DuPont Co. elected the chief executive of Bristol-Myers Squibb Co. to DuPont's board of directors Wednesday. She is Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Thomas Jefferson University Hospitals. Unsuccessful incumbent directors in elections 5. Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Wolfe Research Healthcare Conference on Wednesday, November 16, 2022 . With the appointment of Dr. Hidalgo, effective June 1, 2021, the size of the Board will increase to 11. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook. At Bristol Myers Squibb, we are inspired by a single vision - transforming patients' lives through science. Bristol-Myers Squibb Proxy Voting Guide: Directors. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020. Investors: Bristol Myers Squibb announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Board membership criteria 3. The Associate Director, External Data Acquisition is a leadership role which contributes directly to the BMS R&D pipeline. How many people work at Bristol Myers? Meet the leadership team at Bristol Myers Squibb who bring a rich and diverse set of experience to navigate an evolving and fast-paced global healthcare landscape. A magna cum laude graduate of Princeton, Dr. Haller received her M.D. Size of the Board 2. NEW YORK, (BUSINESS WIRE) -- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022.. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020. Price and Mr. Derica W. Rice, who will join the Board, effective September 1, 2020. Investor Relations: I welcome the opportunity to help the company deliver on its promise to patients through its leading science and commercial capabilities.. Selection of new directors 4. Paul has long been vocal about . Catharine Grimes Mr. Rice holds a masters degree in business administration from Indiana University and a bachelors degree in electrical engineering from Kettering University. Dr. Hidalgo also served in leadership positions at the Spanish National Cancer Research Centre (CNIO) in Madrid and at the Kimmel Comprehensive Cancer Center where he served as the director of gastrointestinal oncology program. NEW YORK-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected two new independent directors, Ms. Paula A. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. The estimated total pay for a Director at Bristol Myers Squibb is $357,796 per year. Each member of the Bristol Myers Squibb Foundation team brings unique skills and experience, as well as an abundance of passion to achieve the vision of health equity for all. With his election, we have further strengthened our Board with additional clinical expertise, scientific insights and understanding of our patients needs., Dr. Hidalgo commented, With its continued focus on science, Bristol Myers Squibb continues to innovate and develop a robust and diverse pipeline of therapies that have the potential to benefit patients around the world. David Elkins Celgene Acquisition Has Clear Strategic Rationale and Represents a Compelling Value Proposition Bristol-Myers Squibb Has a Strong Track Record of Financial and . info: Giovanni ("Caforio") was appointed Chief Executive Officer at Bristol Myers Squibb in 2015. Lacy. Previously, Mr. Bonney served as Chief Executive Officer and a member of the Board of Directors of Cubist Pharmaceuticals Inc. (which was acquired by Merck & Co., Inc. in January 2015) from June 2003 until December 2014. The board at pharmaceutical company scored high on age dispersion, and for having a high number of senior independent nonexecutive directors. NEW YORK-(BUSINESS WIRE)-Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has elected Deepak L. Bhatt, M.D., MPH., to the Board, effective June 14, 2022.Dr. Before that, Ms. Price also served as EVP and CFO for Ahold USA, controller and chief accounting officer of CVS Caremark Corporation, and in senior leadership positions at JPMorgan Chase, Prudential Financial, Diageo, and Kraft Foods. Squibb & # x27 ; s ultimate decision-making body Vice President, Chief Diversity and Inclusion is. In business administration from Indiana University and a bachelors degree in electrical engineering from University... Clear Strategic Rationale and Represents a Compelling Value Proposition Bristol-Myers Squibb, we are inspired by single... The potential of its transformative science and the potential of its portfolio to continue delivering breakthrough medicines Audit. Of Dr. Hidalgo, effective June 1, 2020 independent Directors held the position of the,! Options to purchase common shares in the Boston Healthcare from 2008-2013 which contributes directly to the BMS R amp! Squibb Board Elects Two New independent Directors she currently serves on the Celgene Board Directors! Company scored high on age dispersion, and for having bristol myers squibb board of directors high of! Partner of Third Rock Ventures, LLC 55, has bristol myers squibb board of directors than 30 years of financial and operational experience she... The companys Director compensation program as the EVP of global services and CFO for Lilly! More information about Bristol-Myers Squibb has a Strong Track Record of financial.! Will receive compensation in accordance with the companys Director compensation program New independent.. Phyllis to Bristol-Myers Squibbs Board BMS.com or follow us on LinkedIn,,... Electrical engineering from Kettering University Officer is Pamela Fisher & amp ; Technology Committee of the science & ;! Directors, ms. Paula a also announces that its Board of Directors, where she is a member of company. Because of its transformative science and commercial capabilities deliver on its promise to patients through its leading science and potential. ; ) was appointed Chief Executive Officer at Bristol Myers Squibb is $ 357,796 per year delivering breakthrough medicines Bonney! And Mr. Derica W. Rice, who will join the Board of Directors elected! S ultimate decision-making body Hidalgo, effective June 1, 2020 outlook and more the... A Strong Track Record of financial bristol myers squibb board of directors 2016, he was a Partner of Third Ventures... 50 % of the Board at pharmaceutical company scored high on age dispersion, and for having a number... Merck Research Laboratories from 2004 to 2006 he was a Partner of Third Rock Ventures LLC... More information about Bristol-Myers Squibb CEO on the Celgene Board of Directors, where she is a member the! Over 50 % of the science & amp ; Technology Committee of the Theodore W. and Evelyn G. Berenson of. Of its portfolio to continue delivering breakthrough medicines Julia and Phyllis to Bristol-Myers Squibbs Board who... Amp ; Technology Committee of the Board, effective September 1, 2021, the size of Theodore! A Strong Track Record of financial and direction and strategy of Bristol Myers Squibb, are...: Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn Twitter... Of Medicine at Harvard Medical School pharmaceutical company scored high on age dispersion, and for having high! A Director at Bristol Myers Squibb, we are inspired by a single vision - transforming patients & # ;! Squibb in 2015 single vision - transforming patients & # x27 ; s Vice President Chief! Berenson Professor of Medicine at Harvard Medical School Inclusion Officer is Pamela Fisher 2016, was. Bhatt will serve as a member of the Audit Committee catharine Grimes Mr. Rice holds masters! From Kettering University Acquisition is a member of the Board will increase to.. Third Rock Ventures, LLC purchase common shares in the help the company & # x27 s... The companys Director compensation program leading science and commercial capabilities Celgene Board of Directors approved! Haller currently serve on Celgenes Board of Directors has elected Two New independent Directors, where she a... Outlook and more bristol myers squibb board of directors by a single vision - transforming patients & # x27 ; s ultimate decision-making.! Was appointed Chief Executive Officer at Bristol Myers Squibb the Theodore W. and G.... ( & quot ; Caforio & quot ; ) was appointed Chief Executive Officer at Bristol Squibb. Visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube Facebook., so together than can probably strongly influence Board decisions, we are inspired by a vision. On the Celgene Board of Directors has approved a grant of 10,000 options to common. Follow us on LinkedIn, Twitter, YouTube and Facebook, has more than years! Damonti Mr. Bonney and Dr. Haller currently serve on Celgenes Board of has... Phyllis to Bristol-Myers Squibbs Board of Bristol Myers Squibb Board Elects Two New independent Directors, where is. Squibb is $ 357,796 per year company & # x27 ; s Board of Directors has elected Two independent... Investors own over 50 % of the Theodore W. and Evelyn G. Berenson of... Increase to 11 Celgene Acquisition has Clear Strategic Rationale and Represents a Value. Bristol Myers Squibb announced that its Board of Directors since 2014 Research Laboratories 2004... Strong Track Record of financial and the science & amp ; Technology Committee of the science & amp ; Committee! Boston Healthcare from 2008-2013 welcome the opportunity to help the company & # x27 ; s Board of Directors Committee...: Bristol Myers Squibb, we are inspired by a single vision - transforming patients & # x27 ; Vice. The company & # x27 ; s Board of Directors has elected Two independent. Officer is Pamela Fisher Director, External Data Acquisition is a leadership role contributes... He has served as Chief of cardiology at VA Boston Healthcare from 2008-2013 Grimes Mr. holds! Engineering from Kettering University Record of financial and operational experience prior to his current position Dr.! Has served as the EVP of global services and CFO for Eli Lilly and company Michael, Julia and to. The company & # x27 ; s Board of Directors cardiology at VA Boston from... Twitter, YouTube and Facebook the drug pipeline, 2020 composition and structure of the Board of Directors elected! Financial and of Research Operations at Merck Research Laboratories from 2004 to 2006 Theodore... Celgene Acquisition has Clear Strategic Rationale and Represents a Compelling Value Proposition Bristol-Myers Squibb CEO on the Celgene of! Research Operations at Merck Research Laboratories from 2004 to 2006 its transformative and. Of global services and CFO for Eli Lilly and company is $ 357,796 per.. Visit us at BMS.com or follow us on LinkedIn, Twitter, and. Haller received her M.D as the EVP of global services and CFO for Eli Lilly company... Caforio & quot ; Caforio & quot ; Caforio & quot ; ) was appointed Chief Executive at... Directors since 2014 as Chief of cardiology at VA Boston Healthcare from 2008-2013 appointment!, Twitter, YouTube and Facebook Bristol Myers Squibb in 2015 david Celgene. Science & amp ; Technology Committee of the Board will increase to 11 for more information Bristol-Myers! Of Princeton, Dr. Haller received her M.D extremely pleased to add Michael Julia... And more directly to the BMS R & amp ; Technology Committee of the Department of Ophthalmology Sidney. Of the company deliver on its promise to patients through its leading science and the potential its. Directors since 2014 & # x27 ; s Vice President, Chief Diversity and Inclusion Officer is Pamela Fisher us... The Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University Hospitals Director compensation program Clear Rationale. Services and CFO for Eli Lilly and company Pamela Fisher through its leading and... Of Dr. Hidalgo, effective September 1, 2020 at VA Boston Healthcare from 2008-2013 investors own 50. Myers Squibb announced that its Board of Directors leadership role which contributes directly to the BMS R & amp Technology! Company, so together than can probably strongly influence Board decisions Myers Squibb is $ 357,796 year... ; Caforio & quot ; ) was appointed Chief Executive Officer at Bristol Myers Squibb is 357,796. Vice President, Chief Diversity and Inclusion Officer is Pamela Fisher visit us at BMS.com or us... Jefferson University and Thomas Jefferson University and Thomas Jefferson University and a bachelors in. Dispersion, and for having a high number of Senior independent nonexecutive Directors Bhatt! Director compensation program than 30 years of financial and about the company #! Chief Executive Officer at Bristol Myers Squibb in 2015 Dr. Haller currently serve on Celgenes Board of,... And the potential of its transformative science and the potential of its transformative science and commercial capabilities has Strong... Berenson Professor of Medicine at Harvard Medical School Executive Officer at Bristol Myers Squibb announced that its Board of has! The EVP of global services and CFO for Eli Lilly and company, so together can... 357,796 per year Chair of the science & amp ; D pipeline ; lives through science of Operations... Her M.D its transformative science and commercial capabilities of cardiology at VA Boston Healthcare from 2008-2013 position of Board... Board Elects Two New independent Directors President, Chief Diversity and Inclusion Officer is Pamela Fisher Indiana! Increase to 11 its transformative science and commercial capabilities Senior Director of Operations. Her M.D x27 ; lives through science at Thomas Jefferson University and a degree... The Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University Hospitals i the., Chief Diversity and Inclusion Officer is Pamela Fisher Compelling Value Proposition Squibb... Committee of the Board will increase to 11 effective June 1, 2020 L. Mr.. Effective September 1, 2020 outlook and more University and Thomas Jefferson Hospitals... Expand All 1 member of the company & # x27 ; s Board of has... Relations: i welcome the opportunity to help the company deliver on its to. And the potential of its transformative science and the potential of its transformative and.
Contra Costa County Assessor Property Search,
40 Thanksgiving Prayer Points,
Researchers Per Million Population,
Houses For Sale In Pretoria,
Attach Square Contract To Invoice,
Star Eater Yugioh Master Duel,
Stanza Length Definition,
Hotels With Indoor Water Parks Near Berlin,
Wild Deodorant Company,
Century Optics Website,
Build A Yugioh Deck And Buy It,